Literature DB >> 8432820

Purification of the 115-kilodalton exoantigen of Cryptococcus neoformans and its recognition by immune sera.

A J Hamilton1, J Goodley.   

Abstract

A 115-kDa exoantigen produced by Cryptococcus neoformans recognized by the previously described murine monoclonal antibody 7C9 has been purified from culture filtrate by a combination of membrane ultrafiltration, isoelectric focusing, and preparative gel electrophoresis. It is produced in late-log-phase cultures and is present in greater amounts in cultures grown at 25 degrees C than in those grown at 37 degrees C. Recognition of the antigen by 7C9 on immunoblots is abolished by the proteolytic enzymes papain and trypsin. The antigen is a glycoprotein bearing N-linked oligosaccharides, of which mannose is an important constituent. It does not appear to have proteolytic activity and is acidic, with a pI of 3 to 3.2. Its relationship to previously described C. neoformans mannoprotein is unclear since 7C9 shows only very weak cross-reactivity with a purified sample of the latter. Sera from patients infected with C. neoformans exhibited strong recognition of the glycoprotein as shown by immunoenzyme development of Western immunoblots, indicating its possible significance as a marker of disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432820      PMCID: PMC262761          DOI: 10.1128/jcm.31.2.335-339.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  Soluble polysaccharides of Cryptococcus neoformans.

Authors:  R Cherniak
Journal:  Curr Top Med Mycol       Date:  1988

2.  Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans.

Authors:  E Reiss; R Cherniak; R Eby; L Kaufman
Journal:  Diagn Immunol       Date:  1984

3.  Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans.

Authors:  S H Turner; R Cherniak; E Reiss
Journal:  Carbohydr Res       Date:  1984-02-15       Impact factor: 2.104

4.  Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein.

Authors:  S M Read; D H Northcote
Journal:  Anal Biochem       Date:  1981-09-01       Impact factor: 3.365

5.  Galactoxylomannans of Cryptococcus neoformans.

Authors:  P G James; R Cherniak
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.

Authors:  T R Kozel; E C Gotschlich
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

7.  Cryptococcal meningitis in patients with AIDS.

Authors:  W E Dismukes
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

8.  Commercial cryptococcal latex kit: clinical evaluation in a medical center hospital.

Authors:  E Prevost; R Newell
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

9.  Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens.

Authors:  J W Murphy; R L Mosley; R Cherniak; G H Reyes; T R Kozel; E Reiss
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

10.  Cryptococcal capsular polysaccharide-induced modulation of murine immune responses.

Authors:  J F Breen; I C Lee; F R Vogel; H Friedman
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

View more
  16 in total

Review 1.  Developments in fungal taxonomy.

Authors:  J Guarro; A M Stchigel
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

2.  Production and characterization of recombinant Aspergillus fumigatus Cu,Zn superoxide dismutase and its recognition by immune human sera.

Authors:  M D Holdom; B Lechenne; R J Hay; A J Hamilton; M Monod
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Purification and characterization of a 43-kilodalton extracellular serine proteinase from Cryptococcus neoformans.

Authors:  Jae il Yoo Ji; Yeong Seon Lee; Chul-Yong Song; Bong Su Kim
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

4.  Extracellular proteins of Cryptococcus neoformans and host antibody response.

Authors:  L C Chen; L A Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  An opsonizing monoclonal antibody that recognizes a noncapsular epitope expressed on Cryptococcus neoformans.

Authors:  G J Merkel; B A Scofield
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

6.  Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis.

Authors:  H Kakeya; H Udono; S Maesaki; E Sasaki; S Kawamura; M A Hossain; Y Yamamoto; T Sawai; M Fukuda; K Mitsutake; Y Miyazaki; K Tomono; T Tashiro; E Nakayama; S Kohno
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

7.  Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans.

Authors:  S M Levitz; S Nong ; M K Mansour; C Huang; C A Specht
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

8.  Identification and cloning of a cryptococcal deacetylase that produces protective immune responses.

Authors:  Carmelo Biondo; Concetta Beninati; Demetrio Delfino; Marco Oggioni; Giuseppe Mancuso; Angelina Midiri; Mauro Bombaci; Giuseppe Tomaselli; Giuseppe Teti
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

9.  Specific recognition of purified Cu,Zn superoxide dismutase from Aspergillus fumigatus by immune human sera.

Authors:  A J Hamilton; M D Holdom; R J Hay
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

10.  Humoral response against Cryptococcus neoformans mannoprotein antigens in HIV-infected patients.

Authors:  L Pitzurra; S Perito; F Baldelli; F Bistoni; A Vecchiarelli
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.